Patara Pharma Closes a $26 million Series A Financing and Initiates Phase II Clinical Trials to Evaluate PA101B for Refractory Chronic Cough and Indolent Systemic Mastocytosis

Client News  | 

Now Let's Get Started

See how SVB makes next happen now for entrepreneurs like you.

Connect with Us